EXACT Sciences (EXAS) HR EVP awarded 23,224 RSUs in new grant

(Neutral)

Form Type

Rhea-AI Filing Summary

Condella Sarah reported acquisition or exercise transactions in this Form 4 filing.

EXACT Sciences executive Sarah Condella received an equity award in the form of restricted stock units. On February 25, 2026, the EVP of Human Resources was granted 23,224 restricted stock units at a price of $0.00 per unit.

Each restricted stock unit represents a contingent right to receive one share of common stock and will vest in four equal annual installments beginning on February 25, 2027. After this award, she holds 135,489 shares of common stock (including 129,134 shares held directly and 6,355 shares held indirectly in a 401(k) plan), and in addition holds 75,143 vested and unvested options and restricted stock units.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Condella Sarah

Role EVP, Human Resources

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	23,224	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Units — 23,224 shares (Direct); Common Stock — 129,134 shares (Direct); Common Stock — 6,355 shares (Indirect, Held in 401(k) Plan)

Footnotes (3)

F1. In addition to the shares of Common Stock reported on this Form 4, which total 135,489 shares, Ms. Condella also holds, in the aggregate, an additional 75,143 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
F2. Each restricted stock unit represents a contingent right to receive one share of common stock.
F3. These restricted stock units vest in four equal annual installments beginning on February 25, 2027.

FAQ

What equity award did Sarah Condella receive at EXACT Sciences (EXAS)?

Sarah Condella received a grant of 23,224 restricted stock units. Each unit is a contingent right to one share of EXACT Sciences common stock, vesting over four years starting February 25, 2027, as part of her executive compensation package.

When do Sarah Condella’s new restricted stock units at EXAS vest?

The restricted stock units vest in four equal annual installments beginning on February 25, 2027. This means the award is spread over four years, aligning her compensation with longer-term company performance and ongoing employment at EXACT Sciences.

How many EXACT Sciences common shares does Sarah Condella hold after this filing?

After the reported transactions, Sarah Condella holds 135,489 shares of EXACT Sciences common stock. This includes 129,134 shares held directly and 6,355 shares held indirectly through a 401(k) plan, reflecting her equity stake in the company.

Does Sarah Condella hold additional EXAS equity beyond common shares?

Yes. In addition to 135,489 common shares, she holds 75,143 vested and unvested options and restricted stock units. Each restricted stock unit represents a contingent right to receive one share of EXACT Sciences common stock in the future.

Was the Form 4 for EXAS a purchase or sale by Sarah Condella?

The Form 4 reports an acquisition through a grant of 23,224 restricted stock units, not an open-market purchase or sale. There are no reported buy or sell transactions; it reflects an equity award as part of executive compensation.

How is Sarah Condella’s indirect ownership in EXAS structured?

A portion of Sarah Condella’s EXACT Sciences common stock is held indirectly through a 401(k) plan. The filing reports 6,355 shares of common stock held in this retirement plan, in addition to her larger directly held share position.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/27/2026 - 04:30 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Condella Sarah

(Last)

(First)

(Middle)

C/O EXACT SCIENCES CORP.

5505 ENDEAVOR LANE

(Street)

MADISON

53719

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
EXACT SCIENCES CORP [ EXAS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, Human Resources

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock								129,134⁽¹⁾	D
Common Stock								6,355	I	Held in 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽²⁾	02/25/2026		A		23,224		⁽³⁾	⁽³⁾	Common Stock	23,224	$0	23,224	D

Explanation of Responses:

1. In addition to the shares of Common Stock reported on this Form 4, which total 135,489 shares, Ms. Condella also holds, in the aggregate, an additional 75,143 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.

2. Each restricted stock unit represents a contingent right to receive one share of common stock.

3. These restricted stock units vest in four equal annual installments beginning on February 25, 2027.

	/s/ Sarah Condella by Mark Busch, attorney-in- fact	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR